Site Search

... Governor Josh Shapiro signed Act 39 into law. The legislation will go into effect on January 1, 2025 and will require all state-regulated health plans, including Medicaid, to cover comprehensive biomarker testing, enabling more Pennsylvanians to access the testing that can open the ... the chance to honor them, celebrate their legacy and remind lawmakers that they, too, can honor those lost to cancer by prioritizing access to care and cancer prevention policies, like that which was recently passed in PA to improve patients’ ability to activate biomarker testing and precision medicine in their cancer care,” said American Cancer Society Cancer Action Network (ACS CAN) State Lead Ambassador Donna Kemberling. During this evening’s ceremony, ACS ...

... testing, a game changer in the fight against cancer and an essential step in accessing precision medicine treatments by ensuring state regulated health insurance, including Medicaid, covers appropriate biomarker testing for patients who could benefit. Dubbed ‘the right treatment at the right time,’ precision medicine has played a critical role in improving cancer outcomes. Despite its benefits, health insurance coverage of biomarker testing has not kept pace with innovations in treatment.  “Furthermore, copay accumulator legislation ... affiliate, ACS CAN has successfully advocated for billions of dollars in cancer research funding, expanded access to quality affordable health care, and advanced proven tobacco control measures. We’re more determined than ever to stand together with our volunteers to end cancer as we ...

... The bill requires coverage for biomarker testing when supported by scientific and medical evidence under Florida Medicaid and state-employee health insurance plans. Unfortunately, it leaves out those covered by state-regulated private health insurance plans, which could include tourism, hospitality and agriculture employees who aren’t offered coverage through an employer.  In ... and policymakers to bring this opportunity to the private market. All patients facing cancer and other diseases deserve to get the best possible care. We ask anyone with experience with biomarker testing to share their stories with us so we can further amplify the urgency of this issue.” 0 ...

ATLANTA, GA – February 16, 2023 – The Georgia House yesterday passed bill (HB85) in a 172-2 vote.   Local and national public health groups and hospitals are expressing their support for the bill that would enable more Georgians to access appropriate biomarker testing -- a ... of those scientific advancements but has sent a clear message with the quick advancement of the bill that true progress in Georgians’ health lies in ensuring more people across our great state have access to such innovations.”   “We have made significant strides over the ... treatment options and can help patients avoid treatments that may be ineffective. The innovative testing is increasingly important for cancer care and the treatment of other diseases including arthritis, autoimmune and rare diseases, with research happening in other disease areas.   0 ...